Product Images Apixaban
View Photos of Packaging, Labels & Appearance
- ARISTOTLE Major Bleeding Forest Plot - apixaban tablets 1
- Apixaban Chemical Structure - apixaban tablets 2
- Figure 2 - apixaban tablets 3
- O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08. PAS ESRD Dosing\01. Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg - apixaban tablets 4
- Figure 4 - apixaban tablets 5
- ARISTOTLE Forest Plot - apixaban tablets 6
- pq - apixaban tablets 7
- ab - apixaban tablets 8
Product Label Images
The following 8 images provide visual information about the product associated with Apixaban NDC 0115-1722 by Amneal Pharmaceuticals Of New York Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
ARISTOTLE Major Bleeding Forest Plot - apixaban tablets 1
The provided text seems to be a table presenting data on different subgroups of patients who received Apixaban or Warfarin treatment. The table includes information such as the number of events, number of patients, percentage per year, hazard ratio, and confidence intervals for each subgroup. The data is categorized based on factors like age, sex, weight, prior stroke or TIA, diabetes mellitus, CHADS2 score, creatinine clearance, geographic region, and randomization status. The comparison between Apixaban and Warfarin effectiveness in different subgroups is also indicated in the table. Overall, this information can be used to evaluate the efficacy of Apixaban compared to Warfarin in various patient subgroups.*
Apixaban Chemical Structure - apixaban tablets 2
Figure 2 - apixaban tablets 3
This text provides information on the interacting drug PK Fold Change and 90% CI for various drugs when combined with P-gp and Strong CYP3A4 Inhibitors such as Ketoconazole or Clarithromycin, as well as other CYP3A4 and P-gp Inhibitors like Diltiazem and Naproxen. It also includes data on combined P-gp and Strong CYP3A4 Inducer Rifampin. The values presented indicate AUC and changes relative to reference levels.*
O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08. PAS ESRD Dosing\01. Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg - apixaban tablets 4
This text is a table containing information on population description, PK fold change, and recommendations for dose adjustments based on factors such as renal impairment, age, body weight, and hepatic impairment. It outlines specific changes or adjustments for each factor and provides guidance for dosing based on various conditions and demographics.*
Figure 4 - apixaban tablets 5
This is not a readable text.*
ARISTOTLE Forest Plot - apixaban tablets 6
pq - apixaban tablets 7
ab - apixaban tablets 8
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
